Journal
LIVER INTERNATIONAL
Volume 25, Issue 3, Pages 472-489Publisher
WILEY
DOI: 10.1111/j.1478-3231.2005.01134.x
Keywords
adefovir; chronic hepatitis B; hepatic decompensation; interferon; lamivudine; liver transplantation
Categories
Ask authors/readers for more resources
Background/Aims: A large amount of new data on the treatment of chronic hepatitis B has become available such that the 2003 consensus statement requires revision and update. Methods: New data were presented, discussed and debated in an expert pre-meeting to draft a revision. The revised contents were finalized after discussion in a general meeting of APASL. Results: Conceptual background, including the efficacy and safety profile of currently available and emerging drugs, was reviewed. Nineteen recommendations were formed and unresolved issues and areas for further study were suggested. Conclusion: The current therapy of chronic hepatitis B is modestly effective but not satisfactory. The development of new drugs and new strategies is required to further improve the outcomes of treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available